102 related articles for article (PubMed ID: 3261204)
1. Lymphoma models for B-cell activation and tolerance. VII. Pathways in anti-Ig-mediated growth inhibition and its reversal.
Warner GL; Scott DW
Cell Immunol; 1988 Aug; 115(1):195-203. PubMed ID: 3261204
[TBL] [Abstract][Full Text] [Related]
2. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
[TBL] [Abstract][Full Text] [Related]
3. Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells.
Pennell CA; Scott DW
Eur J Immunol; 1986 Dec; 16(12):1577-81. PubMed ID: 3493148
[TBL] [Abstract][Full Text] [Related]
4. Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells.
Page DM; DeFranco AL
J Immunol; 1988 Jun; 140(11):3717-26. PubMed ID: 2836499
[TBL] [Abstract][Full Text] [Related]
5. Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu.
Scott DW; Livnat D; Pennell CA; Keng P
J Exp Med; 1986 Jul; 164(1):156-64. PubMed ID: 3487612
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by phorbol esters of antiimmunoglobulin-induced calcium signalling and B-cell activation.
Rothstein TL; Kolber DL; Simons ER; Baeker TR
J Cell Physiol; 1986 Dec; 129(3):347-55. PubMed ID: 3491085
[TBL] [Abstract][Full Text] [Related]
7. Activation and proliferation signals in mouse B cells. IX. Protein kinase C activators synergize with non-mitogenic anti-immunoglobulin antibodies to drive B cells into G1.
Bijsterbosch MK; McLaughlin JB; Holman M; Klaus GG
Immunology; 1988 May; 64(1):163-8. PubMed ID: 3260215
[TBL] [Abstract][Full Text] [Related]
8. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines.
Scott DW; O'Garra A; Warren D; Klaus GG
J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976
[TBL] [Abstract][Full Text] [Related]
9. A mutant of the WEHI-231 B lymphocyte line that is resistant to phorbol esters is still sensitive to antigen receptor-mediated growth inhibition.
Haggerty HG; Monroe JG
Cell Immunol; 1994 Mar; 154(1):166-80. PubMed ID: 8118885
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of c-fos expression is a component of the mIg signal transduction mechanism but is not indicative of competence for proliferation.
Monroe JG
J Immunol; 1988 Mar; 140(5):1454-60. PubMed ID: 3126226
[TBL] [Abstract][Full Text] [Related]
11. Selective induction of high levels of IgA synthesis in Peyer's patch B cells by protein kinase C-activating phorbol esters.
Li YS; Dearden-Badet MT; Revillard JP
J Immunol; 1991 Sep; 147(6):1752-8. PubMed ID: 1909730
[TBL] [Abstract][Full Text] [Related]
12. Tumor-promoting phorbol esters suppress receptor-stimulated inositol phospholipid degradation and Ca2+ mobilization in mouse lymphocytes.
Bijsterbosch MK; Klaus GG
Eur J Immunol; 1987 Jan; 17(1):113-8. PubMed ID: 3028820
[TBL] [Abstract][Full Text] [Related]
13. Lymphoma models for B cell activation and tolerance. VIII. Cross-desensitization by sIgM and sIgD and its effects on growth regulation by anti-isotype antibodies.
Alés-Martínez JE; Warner GL; Scott DW
Cell Immunol; 1990 May; 127(2):527-34. PubMed ID: 2328538
[TBL] [Abstract][Full Text] [Related]
14. Molecular events in B cell activation. I. Signals required to stimulate G0 to G1 transition of resting B lymphocytes.
Monroe JG; Kass MJ
J Immunol; 1985 Sep; 135(3):1674-82. PubMed ID: 2410499
[TBL] [Abstract][Full Text] [Related]
15. Regulation of an idiotype+ B cell lymphoma. Effects of antigen and anti-idiotopic antibodies on proliferation and Ig secretion.
Ward RE; McNamara-Ward M; Webb CF; Altman D; Lim PL; Tucker PW; Kohler H
J Immunol; 1988 Jul; 141(1):340-6. PubMed ID: 3259969
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of protein kinase C activity and alpha-isoenzyme expression in murine peritoneal B cells.
Cohen DP; Rothstein TL
J Immunol; 1991 May; 146(9):2921-7. PubMed ID: 2016532
[TBL] [Abstract][Full Text] [Related]
17. Anti-Ig-mediated proliferation of human B cells in the absence of protein kinase C.
Francois DT; Katona IM; June CH; Wahl LM; Feuerstein N; Huang KP; Mond JJ
J Immunol; 1988 May; 140(10):3338-43. PubMed ID: 3129493
[TBL] [Abstract][Full Text] [Related]
18. Lymphoma models for B-cell activation and tolerance. II. Growth inhibition by anti-mu of WEHI-231 and the selection and properties of resistant mutants.
Scott DW; Tuttle J; Livnat D; Haynes W; Cogswell JP; Keng P
Cell Immunol; 1985 Jun; 93(1):124-31. PubMed ID: 3922631
[TBL] [Abstract][Full Text] [Related]
19. Membrane IgM cross-linking is not coupled to protein kinase C translocation in WEHI-231 B lymphoma cells.
Sarthou P; Henry-Toulmé N; Cazenave PA
Eur J Immunol; 1989 Jul; 19(7):1247-52. PubMed ID: 2668012
[TBL] [Abstract][Full Text] [Related]
20. Lymphoma models for B-cell activation and tolerance. IX. Efficient reversal of anti-Ig-mediated growth inhibition by an activated TH2 clone.
Alés-Martínez JE; Silver L; LoCascio N; Scott DW
Cell Immunol; 1991 Jul; 135(2):402-9. PubMed ID: 1828011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
